Skip to main content
logo
Guardant Health, Inc. (FRA:5GH)
Germany flag Germany · Delayed Price · Currency is EUR
94.96
-0.02 (-0.02%)
Last updated: Jan 28, 2026, 8:02 AM CET

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
United States Revenue
851.33M697.16M
International Revenue
51.24M41.85M
Revenue (Total)
902.57M739.02M

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Precision Oncology Testing Revenue
-687.94M
Development Services and Other Revenue
-51.08M
Revenue (Total)
902.57M739.02M

Gross Profit

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Precision Oncology Testing Gross Profit
-427.36M
Development Services and Other Gross Profit
-21.86M
Gross Profit (Total)
902.57M449.22M

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Clinical Test Sales Volume
254.30K206.70K
Biopharmaceutical Test Sales Volume
-40.50K
Updated Sep 30, 2025. Data Source: Fiscal.ai.